PARAMETRIC PORTFOLIO ASSOCIATES LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2022$5,152,000
+51.7%
81,488
+27.2%
0.00%
+50.0%
Q4 2021$3,397,000
-73.0%
64,047
-64.0%
0.00%
-71.4%
Q3 2021$12,559,000
+57.9%
177,915
+49.1%
0.01%
+75.0%
Q2 2021$7,953,000
-27.1%
119,343
+21.5%
0.00%
-33.3%
Q1 2021$10,906,000
-8.5%
98,240
-2.1%
0.01%
-14.3%
Q4 2020$11,917,000
+37.4%
100,354
+0.9%
0.01%
+16.7%
Q3 2020$8,675,000
-2.0%
99,424
+0.6%
0.01%
-14.3%
Q2 2020$8,854,000
-27.7%
98,860
-19.5%
0.01%
-36.4%
Q1 2020$12,242,000
-3.1%
122,841
+11.7%
0.01%
+22.2%
Q4 2019$12,640,000
-17.1%
110,010
-9.0%
0.01%
-25.0%
Q3 2019$15,249,000
+13.2%
120,891
+8.0%
0.01%
+9.1%
Q2 2019$13,474,000
+15.0%
111,962
-16.4%
0.01%
+10.0%
Q1 2019$11,715,000
-40.5%
133,920
-32.0%
0.01%
-50.0%
Q4 2018$19,692,000
-20.5%
196,824
-8.9%
0.02%
-9.1%
Q3 2018$24,766,000
+18.0%
216,145
-7.6%
0.02%
+10.0%
Q2 2018$20,988,000
+43.4%
234,034
+17.0%
0.02%
+42.9%
Q1 2018$14,635,000
+45.3%
200,035
+15.3%
0.01%
+40.0%
Q4 2017$10,074,000
+164.5%
173,454
+104.4%
0.01%
+150.0%
Q3 2017$3,808,000
+20.1%
84,875
+5.7%
0.00%0.0%
Q2 2017$3,170,000
-74.4%
80,272
-73.7%
0.00%
-78.9%
Q1 2017$12,378,000
+312.9%
305,099
+309.1%
0.02%
+375.0%
Q4 2016$2,998,000
-71.4%
74,585
-74.3%
0.00%
-75.0%
Q3 2016$10,500,000
+97.0%
289,969
+57.7%
0.02%
+100.0%
Q2 2016$5,329,000
-27.7%
183,826
-12.8%
0.01%
-33.3%
Q1 2016$7,372,000
+15.8%
210,756
+6.8%
0.01%
+9.1%
Q4 2015$6,364,000
+139.5%
197,387
+140.1%
0.01%
+120.0%
Q3 2015$2,657,000
-23.1%
82,199
-1.6%
0.01%
-28.6%
Q2 2015$3,455,000
-4.4%
83,532
+3.8%
0.01%0.0%
Q1 2015$3,614,000
+43.4%
80,461
+19.4%
0.01%
+40.0%
Q4 2014$2,521,000
+7.8%
67,379
+0.6%
0.01%0.0%
Q3 2014$2,338,000
+25.9%
66,950
+27.2%
0.01%
+25.0%
Q2 2014$1,857,000
+58.4%
52,634
+46.4%
0.00%
+33.3%
Q1 2014$1,172,000
-18.2%
35,953
+5.8%
0.00%0.0%
Q4 2013$1,432,000
+6.2%
33,984
+0.5%
0.00%
-25.0%
Q3 2013$1,349,000
-4.7%
33,827
-1.2%
0.00%0.0%
Q2 2013$1,416,00034,2520.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders